Locally Advanced or Metastatic Renal Cell Carcinoma
Oncology
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
IpsenChina - Tianjin
2 programs1
CabozantinibPhase 2Small Molecule1 trial
Cabozantinib monotherapyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
IpsenCabozantinib
IpsenCabozantinib monotherapy
Clinical Trials (2)
Total enrollment: 374 patients across 2 trials
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
Start: Jan 2020Est. completion: Feb 2026127 patients
Phase 2Completed
Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors
Start: Jan 2020Est. completion: Jun 2020247 patients
N/ACompleted
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
6m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
6m ago
Office Administrator
SystImmune
6m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
16m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
20m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
20m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space